Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer
Gautier Marcq, Luís Souhami, Fabio Cury, Afsar Salimi, Armen Aprikian, Simon Tanguay, Marie Vanhuyse, Raghu Rajan, Fadi Brimo, José João Mansure, Wassim Kassouf
Topics & Concepts
AtezolizumabMedicineTolerabilityBladder cancerToxicityAdverse effectGemcitabineOncologyInternal medicineRadiation therapyUrologyCancerGastroenterologyImmunotherapyPembrolizumabBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersPeptidase Inhibition and Analysis